Altered natural killer cell response in patients with malignant lymphoma.
D003602:Cytotoxicity, Immunologic; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007372:Interferons / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology* / Q000628:therapy
D007372:Interferons